Indegene Limited has announced a board meeting scheduled for October 30, 2025, to review and approve the unaudited consolidated and standalone financial results for the quarter ended September 30, 2025. The meeting will also address matters related to the company’s ESOP and RSU schemes. The trading window, previously closed on October 1, 2025, will reopen 48 hours after the financial results are declared.
Upcoming Board Meeting
A meeting of the Board of Directors of Indegene Limited is scheduled for Thursday, October 30, 2025. During the meeting, the board will consider and approve several key items.
Financial Results Review
The primary agenda includes a review of the unaudited financial results for the quarter ending September 30, 2025. Both consolidated and standalone results will be examined. This includes:
- The unaudited consolidated financial results of the Company and its subsidiaries.
- The unaudited standalone financial results of the Company.
ESOP and RSU Schemes
The board will also discuss matters relating to the company’s employee stock option plan (ESOP) and restricted stock unit (RSU) schemes, specifically:
- Allotment under ESOP Scheme 2020.
- Allotment under RSU Scheme 2020.
Trading Window Closure
As previously announced, the trading window for company securities was closed starting October 1, 2025, to prevent insider trading during the results preparation period. The window will reopen 48 hours after the financial results are formally declared by the company.
Source: BSE
